Exudative (wet) age-related macular degeneration (AMD) is a leading cause of vision loss in the elderly population. Recent advances in treatments can help slow the progression of wet AMD; however, there is currently no cure for this debilitating condition, and treatment adherence can be poor.
The current armamentarium for wet AMD includes anti–vascular endothelial growth factor (VEGF) injections, photodynamic therapy (PDT), and combination treatment. An extensive pipeline of new therapeutics for wet AMD is expected to extend the dosing interval beyond that of currently available agents. The treatment landscape in wet AMD will become much more complex over the next few years, with the potential for improved responses to treatment.
How much do you know about the management of wet AMD? Test your knowledge with this quick quiz.
Medscape © 2020 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: F. Ryan Prall. Fast Five Quiz: Exudative (Wet) Age-Related Macular Degeneration Management - Medscape - Nov 05, 2020.
Comments